Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

374 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Completed

Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes

NCT04316780

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Iowa Iowa City, Iowa, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details
Completed

A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period

NCT03261037

Conditions
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Diseases, +3 more
Locations
  • St. Clare'S Mercy Hospital St. John's, Newfoundland and Labrador, Canada
  • Kingston Health Sciences Centre; research Kingston General Health Research Institute Kingston, Ontario, Canada
  • Dr. Syed Anees Medicine Profession Corporation Windsor, Ontario, Canada
  • Clinique de pneumologie et du sommeil de Lanaudiere Saint-Charles-Borromée, Quebec, Canada
View all 37 locations
View Trial Details
Completed

Toward Self-management in ILD

NCT03300583

Conditions
Chronic Hypersensitivity Pneumonitis, Connective Tissue Related ILD, Fibrotic Lung Disease, +6 more
Locations
  • St George's Hospital London London, United Kingdom
  • University College Hospital London, United Kingdom
View Trial Details
Completed

SD, IL-13 Production Rate in IPF

NCT00532233

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Novartis Investigative Site Denver, Colorado, United States
  • Novartis Investigative Site Atlanta, Georgia, United States
  • Novartis Investigative Site New Orleans, Louisiana, United States
  • Novartis Investigative Site Rochester, Minnesota, United States
View Trial Details

Related conditions